Atlas Trials

Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease

Clinical trial NCT01545050 · TERMINATED

Trial details

NCT number
NCT01545050
Sponsor
CSL Behring
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2012-06-01
Primary completion
2013-12-01
Enrollment
72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.